Literature DB >> 14042730

FURTHER OBSERVATIONS ON RADIOCURABILITY OF A SOLID EHRLICH AND TISSUE REACTIONS IN THE MOUSE WITH FRACTIONATED RADIATION DOSES AND THE EFFECTS OF OXYGEN.

H A VANDENBRENK, K ELLIOTT, H HUTCHINGS.   

Abstract

Entities:  

Keywords:  ANOXIA; ATMOSPHERIC PRESSURE; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; MICE; NEOPLASM RADIOTHERAPY; OXYGEN INHALATION THERAPY; RADIOTHERAPY DOSAGE

Mesh：

Substances：

Year:  1963        PMID： 14042730      PMCID： PMC2070993          DOI： 10.1038/bjc.1963.40

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Estimation of the cellular lethal dose and the critical cell number for the C3H mouse mammary carcinoma from radiosensitivity studies in vivo.

Authors:  A COHEN; L COHEN
Journal:  Nature       Date:  1960-01-23       Impact factor: 49.962

2.  X-ray damage and recovery in mammalian cells in culture.

Authors:  M M ELKIND; H SUTTON
Journal:  Nature       Date:  1959-10-24       Impact factor: 49.962

3.  Effect of immunological attenuation on cell dosage required to establish single or double tumour homografts.

Authors:  H A VAN DEN BRENK
Journal:  Br J Cancer       Date:  1961-12       Impact factor: 7.640

4.  Effect of single and fractionated doses of x-rays on radiocurability of solid Ehrlich tumour and tissue reactions in vivo, for different oxygen tensions.

Authors:  H van den BRENK; K ELLIOTT; H HUTCHINGS
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640
  4 in total
  1 in total

1.  HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism.

Authors:  Minsi Zhang; Qiong Qiu; Zhizhong Li; Mohit Sachdeva; Hooney Min; Diana M Cardona; Thomas F DeLaney; Tracy Han; Yan Ma; Lixia Luo; Olga R Ilkayeva; Ki Lui; Amanda G Nichols; Christopher B Newgard; Michael B Kastan; Jeffrey C Rathmell; Mark W Dewhirst; David G Kirsch
Journal:  Radiat Res       Date:  2015-05-14       Impact factor: 2.841
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.